In conclusion, our study demonstrates that inhibition of the ATases restores proteostatic functions within the ER and can rescue the disease phenotype of AT-1 sTg, a mouse model of segmental progeria, and APP/PS1, a mouse model of AD. Here, SLC33A1 is linked to Alzheimer disease.